Emerging AI Opportunities in Pharmaceuticals and Healthcare with Eli Lilly CIDO Diogo Rau, AstraZeneca CDO & CIO Cindy Hoots, and Bristol Myers Squibb CDTO Greg Meyers
Technovation with Peter High (CIO, CTO, CDO, CXO Interviews)
00:00
Revolutionizing Drug Development with AI
This chapter explores the groundbreaking impact of generative AI on drug development, particularly in clinical trials and patient recruitment. It highlights AI's role in improving research efficiency, enhancing decision-making, and transforming communication within the pharmaceutical industry. The discussion also addresses the challenges of transitioning from tech to pharmaceuticals, emphasizing the need for continuous innovation in a heavily regulated environment.
Play episode from 12:27
Transcript
